Anticoagulation

Ton Duy Mai , Tri Huynh Quang Ho , Sy Van Hoang , et al

Read time: 19m 6s

Bianca Rocca , Hugo ten Cate

Read time: 17m 22s
ACC 25: Optimizing DAPT Duration

Hyo-Soo Kim

Watch time: 9m 39s
ACC 25: The SMART-CHOICE 3 Trial

Joo-Yong Hahn

Watch time: 4m 14s
ACC 25 Late-Breaking Discussion: The API-Cat Study

Harriette Van Spall, Isabelle Mahé

Watch time: 12m 9s
ACC 25: The Phase 3 REVERSE-IT Trial

Deepak L Bhatt

Watch time: 4m 15s

Monika Bhandari , Akshyaya Pradhan , Pravesh Vishwakarma , et al

Read time: 27m 35s
AHA 24: The OPTION Trial

Oussama M Wazni

Watch time: 5m 15s
TCT 24: The PEERLESS Trial

Dr Wissam A Jaber

Watch time: 6m 16s

Mario DiazNuila-Alcazar , Daniel Valcárcel-Paz , Pablo Del Castillo-Vásquez , et al

Read time: 5m
ESC 24: The POPular PAUSE TAVI Trial

Dirk-Jan van Ginkel

Watch time: 7m 9s
ESC 24 Hot Line Discussion: The OCEANIC-AF Trial

Manesh R Patel, Harriette Van Spall

Watch time: 8m 47s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Broadcast

Anticoagulation

Guidelines & Statements
What’s New in the European ACS Guidelines and How Will My Practice Change?

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 36s

Kerry Layne , Albert Ferro

Julia Sikorska , James Uprichard

Mario Petretta , Pierluigi Costanzo , Alberto Cuocolo

Broadcast

Anticoagulation
Prioritising Risk in CAD: A Patient-First Discussion

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

Frédéric Michard

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Yugo Yamashita

Media

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff

Watch time: 10m 36s

Broadcast

Anticoagulation
Prioritising Risk in CAD: A Patient-First Discussion

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Nicolas M Van Mieghem, Joost Daemen

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof

Watch time: 3m 42s

Yugo Yamashita

Broadcast

Anticoagulation

Guidelines & Statements
Clopidogrel or Ticagrelor: Why, When, for Whom?

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan

Watch time: 17m 13s

Media

ACC 25: The SMART-CHOICE 3 Trial

Joo-Yong Hahn

Watch time: 4m 14s
ACC 25: Optimizing DAPT Duration

Hyo-Soo Kim

Watch time: 9m 39s
ACC 25: The Phase 3 REVERSE-IT Trial

Deepak L Bhatt

Watch time: 4m 15s
ACC 25 Late-Breaking Discussion: The API-Cat Study

Harriette Van Spall, Isabelle Mahé

Watch time: 12m 9s
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen

Watch time: 24m 27s
ESC 22: COVID-PACT: Antithrombotic Therapy in Critically Ill COVID-19 Pts

David Berg

Watch time: 4m 51s
ESC 22: ACT: Anti-Coronavirus Therapies to Prevent Progression of COVID-19

Sanjit Jolly

Watch time: 4m 59s
ESC 22: APOLLO: Apixaban for Prevention of Thromboembolic Outcomes in COVID

Renato D Lopes

Watch time: 3m 57s
ESC 23: The ONCO DVT Study

Yugo Yamashita

Watch time: 4m 8s

Nicolas M Van Mieghem, Joost Daemen

Watch time: 1h 35m 42s (16 videos)
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer

Watch time: 1h 5m 20s

Articles

Comparative Analysis of Direct Oral Anticoagulants in Atrial Fibrillation

Ton Duy Mai

,

Tri Huynh Quang Ho

,

Sy Van Hoang

,

Hoai Thi Thu Nguyen

,

Jeyaraj Pandian

,

Tan Van Nguyen

,

Khoa Tien Vu

,

Giang Song Tran

,

Viet Phuong Dao

,

Minh Cong Tran

,

Hung Manh Pham

,

Published:

09 May 2025

Citation:

European Cardiology Review 2025;20:e13.

DOI:

https://doi.org/10.15420/ecr.2025.07
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 724
  • Downloads: Downloads 97
  • Read time: 19m 6s

Factor XI Inhibition and AF

Bianca Rocca

,

Hugo ten Cate

,

Published:

10 April 2025

Citation:

European Cardiology Review 2025;20:e08.

DOI:

https://doi.org/10.15420/ecr.2024.61
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 356
  • Downloads: Downloads 27
  • Read time: 17m 22s

Anticoagulant Use in Older Adults

Monika Bhandari

,

Akshyaya Pradhan

,

Pravesh Vishwakarma

,

Laura Di Renzo

,

Ferdinando Iellamo

,

Wahid Ali

,

Marco Alfonso Perrone

,

Published:

20 February 2025

Citation:

European Cardiology Review 2025;20:e03.

DOI:

https://doi.org/10.15420/ecr.2024.17
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1929
  • Downloads: Downloads 164
  • Read time: 27m 35s

Oral Anticoagulation and Prognosis of Patients with Atrial Fibrillation After Ischemic Stroke: A Real-world Data Analysis

Mario DiazNuila-Alcazar

,

Daniel Valcárcel-Paz

,

Pablo Del Castillo-Vásquez

,

Marcel Santaló-Corcoy

,

Walter Bragagnini

,

Joan Carles Oliva-Morera

,

Eduardo Bosch-Peligero

,

Antoni Martínez-Rubio

,

Citation:

European Cardiology Review 2017;12(2):95.

DOI:

https://doi.org/10.15420/ecr.2017:23:4
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 112
  • Downloads: Downloads 3
  • Citations: 1
  • Read time: 5m